Abstract
The in vitro activity of a series of ruthenium clusters, [(η6-C6H6)(η6-C6Me6)2Ru3(μ-H)3(μ3-O)][BF4], [(η6-C6H6)(η6-1,4-iPrC6H4Me)(η6-C6Me6)Ru3(μ-H)3(μ3-O)][BF4], [(η6-C6H6)4Ru4(μ-H)4][BF4]2, [(η6-C6H5Me)4Ru4(μ-H)4][BF4]2 and [(η6-C6H6)4Ru4(μ-H)3(μ-OH)][Cl]2, has been evaluated against A2780 and A2780cisR ovarian carcinoma cell lines. Both triruthenium clusters are very active compared to ruthenium compounds in general, whereas the tetraruthenium clusters do not display significant cytotoxicities. Since the triruthenium clusters are known to form supramolecular interactions with arenes and other functions, it is possible that such interactions are also important with respect to their mode of biological activity. The X-ray structure analysis of [(η6-C6H5Me)4Ru4(μ-H)4][PF6]2 is also reported.
Graphical Abstract
The in vitro activity of a series of ruthenium clusters has been evaluated against A2780 and A2780cisR ovarian carcinoma cell lines and their activity compared to cisplatin. The triruthenium clusters are very active, while the tetraruthenium clusters do not display significant cytotoxicities.
Similar content being viewed by others
References
E. Alessio, G. Mestroni, A. Bergamo, G. Sava (2004), Met. Ions Biol. Syst. 42, 323
(a) C. G. Hartinger, S. Zorbas-Selfried, M. A. Jakupec, B. Kynast, H. Zorbas and B. K. Keppler (2006), J. Inorg. Biochem. 100, 891. (b) E. Alessio, G. Mestroni, A. Bergamo and G. Sava (2004), Curr. Top. Med. Chem. 4, 1525
(a) A. R. Timerbaev, C. G. Hartinger, S. S. Aleksenko and B. K. Keppler (2006), Chem. Rev. 106, 2224. (b) P. J. Dyson and G. Sava (2006) Dalton Trans., 1929
(a) C. S. Allardyce, A. Dorcier, C. Scolaro and P. J. Dyson (2005), Appl. Organomet. Chem. 19, 1. (b) A. Vessieres, S. Top, W. Beck, E. Hillard and G. Jaouen (2006), Dalton Trans. 529
(a) W. H. Ang and P. J. Dyson (2006), Eur. J. Inorg. Chem. 4003. (b) M. Melchart and P. J. Sadler (2006), Bioorganometallics (Ed. Jaouen, G.), Wiley-VCH, Weinheim
D. N. Akbayeva, L. Gonsalvi, W. Oberhauser, M. Peruzzini, F. Vizza, P. Brüggeller, A. Romerosa, G. Sava and A. Bergamo (2003), Chem. Commun. 264
B. Serli, E. Zangrando, T. Gianferrara, C. Scolaro, P. J. Dyson, A. Bergamo and E. Alessio (2005), Eur. J. Inorg. Chem. 3423
A. Dorcier, W. H. Ang, S. Bolaño, L. Gonsalvi, L. Juillerat-Jeanneret, G. Laurenczy, M. Peruzzini, A. D. Phillips, F. Zanobini, P. J. Dyson (2006), Organometallics 25, 4090
C. Scolaro, A. Bergamo, L. Brescacin, R. Delfino, M. Cocchietto, G. Laurenczy, T. J. Geldbach, G. Sava, P. J. Dyson (2005), J. Med. Chem. 48, 4161
C. A. Vock, W. H. Ang, C. Scolaro, A. D. Phillips, L. Lagopoulos, L. Juillerat-Jeanneret, G. Sava, R. Scopelliti, P. J. Dyson (2007), J. Med. Chem., 50, 2166
(a) C. S Allardyce and P. J. Dyson (2001), J. Cluster Sci. 12, 563. (b) E. Rosenberg, F. Spada, K. Sugden, B. Martin, L. Milone, R. Gobetto, A. Viale and J. Fiedler (2003), J. Organomet. Chem. 668, 51
D. Colangelo, A. Ghiglia, A. Ghezzi, M. Ravera, E. Rosenberg, F. Spada, D. Osella (2005), J. Inorg. Biochem., 99, 505
D. F. Baban, L. W. Seymour (1998), Adv. Drug Delivery Rev. 34, 109
C. S. Allardyce, P. J. Dyson, D. J. Ellis, P. A. Salter, R. Scopelliti (2003), J. Organomet. Chem. 668, 35
M. Faure, M. Jahncke, A. Neels, H. Stoeckli-Evans, G. Süss-Fink (1999), Polyhedron, 18, 2679
L. Vieille-Petit, G. Süss-Fink, B. Therrien, T. R. Ward, H. Stoeckli-Evans, G. Labat, L. Karmazin-Brelot, A. Neels, T. Bürgi, R. G. Finke, C. M. Hagen (2005), Organometallics, 24, 6104
G. Meister, G. Rheinwald, H. Stoeckli-Evans and G. Süss-Fink (1994), J. Chem. Soc., Dalton Trans., 3215
F. Chérioux, A. Maisse-François, A. Neels, H. Stoeckli-Evans and G. Süss-Fink (2001), J. Chem. Soc., Dalton Trans., 2184
C. A. Vock, C. Scolaro, A. D. Phillips, R. Scopelliti, G. Sava, P. J. Dyson (2006), J. Med. Chem., 49, 5552
W. H. Ang, P. J. Dyson, B. Therrien and G. Süss-Fink, unpublished results
(a) L. Vieille-Petit, B. Therrien, G. Süss-Fink and T. R. Ward (2003), J. Organomet. Chem. 684, 117. (b) B. Therrien, L. Vieille-Petit and G. Süss-Fink (2004), Inorg. Chim. Acta. 357, 3284
(a) B. Therrien, L. Vieille-Petit, G. Süss-Fink, Y. Sei and K. Yamaguchi (2004), J. Organomet. Chem. 689, 2820. (b) B. Therrien, L. Vieille-Petit and G. Süss-Fink (2005), J. Mol. Struct. 749, 183
M. A. Bennett, A. K. Smith (1974), J. Chem. Soc., Dalton Trans. 233
G. M. Sheldrick (1997), SHELXS-97, University of Göttingen, Göttingen, Germany
G. M. Sheldrick (1997), SHELXL-97, University of Göttingen, Göttingen, Germany
L. J. Farrugia (1997), J. Appl. Cryst. 30, 565
Acknowledgement
The authors are grateful to the Fonds National Suisse de la Recherche Scientifique for financial support. A generous loan of ruthenium chloride hydrate from the Johnson Matthey Technology Centre is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Dedicated to Professor Dieter Fenske on the occasion of his 65th birthday anniversary
Rights and permissions
About this article
Cite this article
Therrien, B., Ang, W.H., Chérioux, F. et al. Remarkable Anticancer Activity of Triruthenium-Arene Clusters Compared to Tetraruthenium-Arene Clusters. J Clust Sci 18, 741–752 (2007). https://doi.org/10.1007/s10876-007-0140-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-007-0140-y